Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
Clinical trial NCT02227238 · COMPLETED
Trial details
- NCT number
- NCT02227238
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-11
- Primary completion
- 2017-08-02
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.